SMN1 and proximal spinal muscular atrophy: In addition to PTM, specific RBPs have therapeutic potential in treating diseases through other pathways, for example, the survival of motor neuron 1 (SMN1) gene, whose mutation or deletion is a major cause of spinal muscular atrophy (SMA) [118].